Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
S-64315 by Les Laboratoires Servier for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute...
S-64315 by Les Laboratoires Servier for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase I for Relapsed Acute Myeloid Leukemia. According...
S-64315 by Les Laboratoires Servier for Refractory Acute Myeloid Leukemia: Likelihood of Approval
S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase I for Refractory Acute Myeloid Leukemia. According...
S-64315 by Les Laboratoires Servier for Non-Hodgkin Lymphoma: Likelihood of Approval
S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData,...
S-64315 by Les Laboratoires Servier for Refractory Multiple Myeloma: Likelihood of Approval
S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase I for Refractory Multiple Myeloma. According to...